Bayesian Capital Management »

Denali Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $138k 10k 13.60
2024-12-31 $384k 19k 20.38
2024-09-30 $233k 8.0k 29.13
2024-06-30 $1.2M 51k 23.22
2024-03-31 $447k 22k 20.52
2023-09-30 $288k 14k 20.63